Not close to an in-person session? Learn more about our live webinars.

If you have been diagnosed with polycythemia vera (PV) or myelofibrosis (MF), you may have questions about the treatment options that are available. The INFOCUS patient education session will provide information about your condition and select treatment options, primarily Jakafi® (ruxolitinib). Join us for a free live session where you will hear from an Incyte Oncology Nurse Educator and meet others like you.

What to expect at the live educational session

Hear from an Incyte Oncology Nurse Educator who may be able to help answer your questions.

Learn LEARN about PV and MF
Connect CONNECT with people like you and learn how to partner with your healthcare professional
Explore EXPLORE some select treatment options, including Jakafi
Discuss DISCUSS the importance of a management plan and setting goals

The speaker will not provide medical advice. Your healthcare professional is the best source of information about your health.
Only your healthcare professional can decide if Jakafi is right for you.

Jakafi is a prescription medicine used to treat people with polycythemia vera who have already taken a medicine called hydroxyurea and it did not work well enough or they could not tolerate it.

Jakafi is also used to treat certain types of myelofibrosis.

UPCOMING SESSIONS

There are no upcoming sessions at this time.
Check back soon!

What is Jakafi?

Jakafi is the first and only prescription medicine for treatment of people with polycythemia vera who have already taken a medicine called hydroxyurea and it did not work well enough or they could not tolerate it. Jakafi is also the first and only prescription medicine approved to treat people with intermediate or high-risk myelofibrosis.

FIND A SESSION NEAR YOU

JOIN US!

Please complete and submit the registration form below

REGISTRATION

The speaker will not provide medical advice. Your healthcare professional is the best source of information about your health.

Only your healthcare professional can decide if Jakafi is right for you.

Jakafi is a prescription medicine used to treat people with polycythemia vera who have already taken a medicine called hydroxyurea and it did not work well enough or they could not tolerate it.

Jakafi is also used to treat certain types of myelofibrosis.

All Fields Required

*Please note that any meal or other item of value may be restricted or reported in accordance with state and federal law governing interactions with healthcare professionals.

Vertical Tabs

Consent for Use of Personal Information

By clicking “SUBMIT” below, I authorize Incyte Corporation (“Incyte”) and its agents to use my registration information provided above (my “Information”) to contact me in order to (i) provide education and ongoing support services to me related to treatment, disease and other areas of interest; (ii) provide information about Incyte products and services; and (iii) provide company updates about Incyte. I understand that I may at any time revoke my consent to be contacted for any of these purposes by either following the “unsubscribe” link on electronic messages or “opting out” at Incyte.com.

I also authorize Incyte and its agents to (i) combine my Information with that of other registrants to create aggregated, anonymized data and to use and share the anonymized data for any legitimate purpose; and (ii) to use and disclose my Information for any other purpose described in Incyte’s Privacy Policy. I understand that Incyte’s Privacy Policy may change from time to time and that I should check the website for the most recent version, as well as for the most recent version of Incyte’s Legal Notices.

Questions?

Call us: 919-256-2472

Email us: info@INFOCUSMEETING.com